Skip to search formSkip to main contentSkip to account menu

RS 102221

Known as: RS-102221 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The present study examined the roles of 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes in mediating the ventrolateral orbital cortex… 
2018
2018
PURPOSE To determine the serotonergic (5HT) receptor subtype mediating the contraction of bovine posterior ciliary arteries… 
2008
2008
This study investigated the effects of two selective serotonin2C (5-hydroxytryptamine, 5-HT2C) receptor-acting compounds into the… 
2006
2006
Injection of RS 102221 (selective antagonist of serotonin 5-HT2C receptors) in a dose of 2 mg/kg reduced anxiety of mice in the… 
2006
2006
PURPOSE AND METHODS The aim of this study was to characterize the serotonin (5-hydroxytryptamine; 5-HT) receptors that mediate… 
1999
1999
The primary aim of this investigation was to determine whether binding sites corresponding to the 5‐HT7 receptor could be…